Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 2
1950 1
1951 1
1953 2
1954 3
1955 1
1956 4
1957 2
1958 1
1959 3
1960 2
1962 1
1963 1
1964 2
1965 1
1966 1
1967 2
1968 2
1969 4
1970 4
1971 1
1972 1
1973 1
1974 4
1975 3
1978 1
1979 1
1982 1
1984 1
1986 3
1987 6
1988 3
1989 1
1990 1
1991 3
1992 2
1993 2
1994 5
1995 3
1997 2
1998 1
1999 4
2000 1
2001 3
2002 1
2003 1
2004 7
2005 7
2006 4
2007 8
2008 6
2009 7
2010 11
2011 9
2012 9
2013 8
2014 8
2015 15
2016 12
2017 15
2018 14
2019 6
2020 9
2021 7
2022 4
2023 2
2024 10
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

245 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis.
Boesjes CM, Kamphuis E, de Graaf M, Spekhorst LS, Haeck I, van der Gang LF, Loman L, Zuithoff NPA, Dekkers C, van der Rijst LP, Romeijn GLE, Oosting AJ, Gostynksi A, van Lynden-van Nes AMT, Tupker RA, van Tuyll van Serooskerken AM, Flinterman A, Politiek K, Touwslager WRH, Christoffers WA, Stewart SM, Kamsteeg M, Schuttelaar MA, de Bruin-Weller MS. Boesjes CM, et al. Among authors: stewart sm. JAMA Dermatol. 2024 Oct 1;160(10):1044-1055. doi: 10.1001/jamadermatol.2024.2517. JAMA Dermatol. 2024. PMID: 39110432
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
Zhang J, Boesjes CM, Loman L, Kamphuis E, Romeijn MLE, Spekhorst LS, Haeck I, van der Gang LF, Dekkers CC, van der Rijst LP, Oosting AJ, van Lumig P, van Lynden-van Nes AMT, Tupker RA, Nijssen A, Flinterman A, Politiek K, Touwslager WRH, Christoffers WA, Stewart SM, Kamsteeg M, de Graaf M, de Bruin-Weller MS, Schuttelaar MA. Zhang J, et al. Among authors: stewart sm. J Am Acad Dermatol. 2024 Aug;91(2):300-311. doi: 10.1016/j.jaad.2024.04.026. Epub 2024 Apr 21. J Am Acad Dermatol. 2024. PMID: 38653344 Free article.
Ethionamide.
RIDDELL RW, STEWART SM, SOMNER AR. RIDDELL RW, et al. Among authors: stewart sm. Br Med J. 1960 Oct 22;2(5207):1207-8. doi: 10.1136/bmj.2.5207.1207. Br Med J. 1960. PMID: 13741471 Free PMC article. No abstract available.
Cohort Profile: FAMILY Cohort.
Leung GM, Ni MY, Wong PT, Lee PH, Chan BH, Stewart SM, Schooling CM, Johnston JM, Lam WW, Chan SS, McDowell I, Lam TH, Pang H, Fielding R. Leung GM, et al. Among authors: stewart sm. Int J Epidemiol. 2017 Apr 1;46(2):e1. doi: 10.1093/ije/dyu257. Int J Epidemiol. 2017. PMID: 25617647
Droperidol.
Stewart SM. Stewart SM. Crit Care Nurse. 1987 Sep-Oct;7(5):86. Crit Care Nurse. 1987. PMID: 3665555 No abstract available.
Narcan (naloxone HCl).
Stewart SM. Stewart SM. Crit Care Nurse. 1984 May-Jun;4(3):20-1. Crit Care Nurse. 1984. PMID: 6563964 No abstract available.
245 results